Partnered with SRx Health Solutions and BioScript Solutions to Build Out a Network of NeonMind-branded Specialty Mental Health Clinics Across Canada OAKVILLE, ON / ACCESSWIRE / April 12, 2022 / NeonMind...
Psychedelics could soon revolutionize the $2.5 trillion mental health market. In fact, according to co-CEO of the ATMA Journey Centers, David Harder, a quoted in a company press release, “The surge...
The world may be a step closer to successfully treating obesity with psilocybin. That's because psilocybin activates serotonin receptors, or "nature's own appetite suppressant," as noted by Psychology...
NeonMind Biosciences (CSE: NEON) (OTC: NMDBF) is another step closer to treating the global obesity epidemic. At the moment, worldwide obesity has tripled since 1975, says the World Health Organization....
NeonMind Biosciences (CSE:NEON)(OTC:NMDBF) is a step closer to bringing innovative psychedelic-based treatments to people suffering from obesity and mental health disorders. With obesity, for example,...
Mental health is on the decline all over the world. In the U.S. for example, the White House noted, “Our country faces an unprecedented mental health crisis among people of all ages. Two out of five...
Demand for mental healthcare is on the rise. In fact, “As the impact of the pandemic on mental health continues, psychologists are reporting a large increase in demand for treatment of anxiety and depression...
Mental health is on the decline all over the world. In fact, as reported by Sky News, a report authored by the Lancet-World Psychiatric Association Commission estimates that, “around 5 per cent of the...
Psychedelics could be a game-changer in the treatment of mental health. So far, studies show how useful they can be in treating mental health issues, such as obsessive compulsive disorder, PTSD, opioid...
VANCOUVER, BC / ACCESSWIRE / December 2, 2021 / NeonMind Biosciences Inc. (CSE:NEON) (OTCQB:NMDBF) (FRA:6UF) ("NeonMind'' or the "Company"), an integrated drug development and wellness company focused...